No.9 Courtyard, Shengmingyuan Road, Beijing, Changping District, 102206, China
Overview
BoomRay Pharmaceuticals is a Chinese biotech firm. According to the article, it raised 300 million yuan (about $43.4 million) in a Series B round. The Series B was led by Sequoia China. The article does not provide details on BoomRay’s products, pipeline, or operating metrics. No information on founding year, prior rounds, valuation, or future plans was included in the report.
